PSNLHIGH SIGNALFINANCIAL10-K

PSNL shows severe cash burn acceleration with operating cash flow deteriorating 66% to -$74.9M despite growing revenue indicators and successful equity fundraising.

The dramatic worsening of operating cash flow coupled with a 29% increase in operating losses signals concerning operational inefficiency despite business growth. However, the company successfully raised capital (evident from 18% share count increase and 36% cash position improvement), providing runway but at significant dilution to existing shareholders.

Comparing 2026-02-26 vs 2025-02-27View on EDGAR →
FINANCIAL ANALYSIS

PSNL demonstrates a mixed financial picture with strong growth indicators including 99% increase in accounts receivable and 32% growth in current assets, suggesting expanding business activity, while maintaining a healthy cash position that grew 36% to $124.2M through equity financing. However, the operational metrics are deeply concerning with operating cash flow deteriorating 66% to -$74.9M and operating losses expanding 29% to -$88.1M, indicating the company is burning through cash at an accelerating rate despite revenue growth. The 18% increase in share count from ~88M to ~105M shares reflects significant equity dilution, though it has provided necessary capital to fund operations and increased capex investments.

FINANCIAL STATEMENT CHANGES
Interest Expense
P&L
+754.2%
$24K$205K

Interest expense surged 754.2% — significant debt increase or rising rates materially impacting earnings.

Capital Expenditure
Cash Flow
+181%
$1.6M$4.5M

Capital expenditure jumped 181% — major investment cycle underway; assess returns on deployment.

Accounts Receivable
Balance Sheet
+99.1%
$8.1M$16.2M

Receivables surged 99.1% — revenue recognized but not yet collected; watch for collection issues or channel stuffing.

Operating Cash Flow
Cash Flow
-66%
-$45.1M-$74.9M

Operating cash flow fell 66% — earnings quality concerns; investigate working capital changes and non-cash items.

Cash & Equivalents
Balance Sheet
+35.9%
$91.4M$124.2M

Cash position surged 35.9% — strong cash generation or capital raise providing significant financial cushion.

Current Assets
Balance Sheet
+32%
$203.0M$268.0M

Current assets grew 32% — improving short-term liquidity or inventory/receivables build.

Operating Income
P&L
-29%
-$68.3M-$88.1M

Operating profitability softening — costs rising faster than revenue, watch for margin recovery plan.

Stockholders Equity
Balance Sheet
+28.7%
$203.0M$261.2M

Equity base grew 28.7% — retained earnings accumulation or equity issuance strengthening the balance sheet.

Current Liabilities
Balance Sheet
+27.3%
$31.1M$39.6M

Current liabilities rose 27.3% — increased short-term obligations, watch current ratio.

Total Assets
Balance Sheet
+23.6%
$270.3M$334.2M

Asset base grew 23.6% — expansion through organic growth, acquisitions, or capital deployment.

LANGUAGE CHANGES
NEW — 2026-02-26
PRIOR — 2025-02-27
ADDED
104,631,832 shares of common stock were issued and outstanding as of February 20, 2026.
Department of Veterans Affairs' Million Veteran Program ( VA MVP ), ModernaTX, Inc.
( Merck ), and other collaboration partners and customers; our belief that approval of personalized cancer therapies by the U.S.
We are pursuing a partner-centric strategy and have key relationships with Tempus, Myriad Genetics, Inc., Moderna, and Merck, among others.
International trade policies, including tariffs, sanctions and trade barriers may adversely affect our business, financial condition, results of operations and prospects.
+7 more — sign up free →
REMOVED
88,263,269 shares of common stock were issued and outstanding as of February 21, 2025.
Department of Veterans Affairs' Million Veteran Program, Natera, Inc., Moderna, Inc.
("Moderna"), and other collaboration partners and customers; our belief that approval of personalized cancer therapies by the U.S.
We are pursuing a partner-centric strategy and have key relationships with Tempus, Myriad Genetics, Inc, Moderna, and Merck Co., Inc., among others.
Our employees may engage in misconduct or other improper activities, such as noncompliance with regulatory standards and requirements, including the Foreign Corrupt Practices Act of 1977 and other anti-bribery laws, which could cause significant liability for us and harm our reputation.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
PNRGHIGHPNRG achieved exceptional profitability improvement with net income surging 2,21...
2026-04-16
BNAIHIGHBNAI underwent a dramatic reverse stock split that reduced share count by 86% wh...
2026-04-16
LAKEHIGHLAKE's financial performance deteriorated significantly with operating losses wo...
2026-04-16
NXXTHIGHNextNRG experienced massive financial deterioration with operating losses explod...
2026-04-16
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →